LOADING
Comparing UnitedHealth Group (UNH) and Johnson & Johnson (JNJ), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | UNH | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $327.8B | $623.3B |
| P/E Ratio | 23.6 | 30.7 |
| Forward P/E | 16.6 | 21.0 |
| PEG Ratio | 1.01 | 2.82 |
| EPS | $15.48 | $8.43 |
| Revenue Growth (YoY) | 0.4% | 6.6% |
| Profit Margin | 3.1% | 21.5% |
| Return on Equity | 14.1% | 25.7% |
| Dividend Yield | 2.44% | 1.98% |
| Beta | 0.62 | 0.23 |
| 52-Week High | $458.79 | $281.07 |
| 52-Week Low | $252.96 | $178.89 |
| Volume | -- | -- |
Johnson & Johnson is the larger company by market capitalization. UnitedHealth Group trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. UnitedHealth Group offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.